IP Library › Granted Patent US 12,533,255
Granted Patent B2
US 12,533,255 · App. 18/663,647 · Granted Jan 27, 2026

Cervical collar

Inventor: Robert Michael Maher (Columbus, OH)
Assignee: NeuroRescue Inc.
A61F5/055A61F7/0085A61F7/10A61F2007/0012A61F2007/0056A61F2007/0095A61F2007/0228A61F2007/0273
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,533,255
App. No.
18/663,647
Granted
Jan 27, 2026
Kind
B2
Abstract

A cervical collar that facilitates therapeutic hypothermia is provided and includes a cooling device having a front portion and a back portion fixedly coupled to the front portion on one side and removably coupled to the front portion on an opposite side. A fastening device removably couples the back portion to the front portion on the opposite side. The cooling device induces hypothermia in at least a portion of a patient. A sensor is provided that measures a physical characteristic of the patient.

Claims (30)

1 . A system that facilitates temperature modulation, comprising:

a temperature altering substance capable of raising or lowering based upon a benchmark temperature; and

a device that includes a chamber configured to retain a temperature altering substance, wherein the device at least partially encloses a bodily region of the user, wherein the system selectively targets a portion of the bodily region of the user thereby altering a temperature of the portion of the bodily region of the user via the temperature altering substance.

2 . The system of claim 1 , wherein the system further comprises at least one passageway that fluidly connects the chamber with a heating or cooling source.

3 . The system of claim 2 , wherein the at least one passageway further includes at least one inlet port and at least one outlet port that provide a connection between the heating/cooling source and the chamber.

4 . The system of claim 3 , wherein the heating or cooling source comprises a first portable temperature control pack comprising the temperature altering substance.

5 . The system of claim 4 , wherein the first portable temperature control pack is connected to the at least one inlet port and wherein the temperature altering substance may enter into the chamber via the at least one inlet port.

6 . The system of claim 1 wherein that chamber is embodied within a bladder, and wherein at least a portion of the bladder is at least semi-transparent enabling a visual inspection of the temperature altering substance within the chamber.

7 . The system of claim 6 wherein the temperature altering substance changes color in accordance with a temperature.

8 . The system of claim 7 , wherein the temperature is a temperature of the portion of the bodily region of the user.

9 . The system of claim 1 , further comprising a temperature color changeable tag fixedly attached to the device, wherein the tag is configured to change color corresponding to a change of a temperature of the portion of the bodily region of the user or the temperature altering substance.

10 . The system of claim 1 , wherein the temperature altering substance is mechanically pumped or manually squeezed through an inlet port of the bladder or into the chamber.

11 . A therapeutic device comprising:

an outer surface and an inner surface forming a cavity therebetween;

a chamber disposed within the cavity between the outer surface and the inner surface, wherein the chamber is configured to maintain fluid, wherein the therapeutic device at least partially encloses a body region of a user; and

wherein the fluid in the chamber affects blood flowing through cerebral vasculature thereby altering a temperature of the blood flowing through the cerebral vasculature.

12 . The therapeutic device of claim 11 , further comprising an indicator that changes color based on a change in a measurable event.

13 . The therapeutic device of claim 12 , wherein the indicator is the chamber.

14 . The therapeutic device of claim 13 , wherein at least a portion of the therapeutic device is at least semi-transparent enabling a visual inspection of the chamber.

15 . The therapeutic device of claim 13 , wherein the chamber is segmented and connected by a passageway, wherein the passageway provides a connection between a portable fluid source and at least one segment of the chamber.

16 . The therapeutic device of claim 12 , wherein the indicator is a tag fixedly attached to the therapeutic device.

17 . A method of modulating body temperature or a user, comprising:

placing a wrap or pad on a bodily region of the user, the wrap or the pad comprising a bladder configured to retain a fluid and to selectively contact portions of the bodily region of the user;

monitoring a temperature of the fluid inside the bladder; and

indicating the temperature via a visual indicator.

18 . The method of claim 17 further comprising:

determining a target region of the user's body; and

configuring the wrap or the pad to contact the target region.

19 . The method of claim 17 , wherein the wrap or the pad comprises an indicator that changes color based on a change in a measurable event.

20 . The method of claim 17 , wherein the indicator is the bladder, and wherein at least a portion of the wrap or the pad is at least semi-transparent enabling a visual inspection of the bladder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2025
From: MAHER, ROBERT MICHAEL
To: NEURORESCUE, INC.
Reel/Frame 070767/0913 →
Continuity (10)
Continuation 17571756 · Jan 10, 2022
Continuation 16528046 · Jul 31, 2019
Continuation 16528090 · Jul 31, 2019
Continuation In Part 15287227 · Oct 6, 2016
Continuation In Part 15287227 · Oct 6, 2016
Continuation In Part 14052346 · Oct 11, 2013
Continuation In Part 13309173 · Dec 1, 2011
Provisional Application 62834781 · Apr 16, 2019
Provisional Application 61419018 · Dec 2, 2010
Related Publication 20240293247A1 · Sep 5, 2024
References Cited (37)
US 2250840A · Pomeranz · 1941 [cited by applicant]
US 4745922A · Taylor · 1988 [cited by applicant]
US 4821354A · Little · 1989 [cited by applicant]
US 4886063A · Crews · 1989 [cited by applicant]
US 5038759A · Morgenstern · 1991 [cited by applicant]
US 5072875A · Zacoi · 1991 [cited by applicant]
US 5211623A · Sarkozi · 1993 [cited by applicant]
US 5415624A · Williams · 1995 [cited by applicant]
US 5449379A · Hadtke · 1995 [cited by applicant]
US 5871526A · Gibbs et al. · 1999 [cited by applicant]
US 6152953A · Hipskind · 2000 [cited by applicant]
US 6183501B1 · Latham · 2001 [cited by applicant]
US 6561995B1 · Thibodo · 2003 [cited by applicant]
US 6602213B1 · Figley · 2003 [cited by applicant]
US 6840955B2 · Ein · 2005 [cited by applicant]
US 7785359B2 · Latham · 2010 [cited by applicant]
US 7846118B2 · Sandhu · 2010 [cited by applicant]
US 7861326B2 · Harty · 2011 [cited by applicant]
US 9486354B2 · Maher · 2016 [cited by examiner]
US 10426658B2 · Maher · 2019 [cited by examiner]
US 11219546B2 · Maher · 2022 [cited by examiner]
US 11224533B2 · Maher · 2022 [cited by examiner]
US 11229547B2 · Makarov et al. · 2022 [cited by applicant]
US 11458039B2 · Zak, III et al. · 2022 [cited by applicant]
US 12011382B2 · Maher · 2024 [cited by examiner]
US 20030236561A1 · Lennox · 2003 [cited by applicant]
US 20050284416A1 · Smit · 2005 [cited by applicant]
US 20060079820A1 · Sandhu · 2006 [cited by applicant]
US 20080269852A1 · Lennox et al. · 2008 [cited by applicant]
US 20100305669A1 · Sasaki · 2010 [cited by applicant]
US 20110054577A1 · Latham · 2011 [cited by applicant]
US 20130030341A1 · Freer et al. · 2013 [cited by applicant]
US 20140128945A1 · Schoning · 2014 [cited by applicant]
International Search Report for International Patent Application No. PCT/US2011/063021 dated Mar. 9, 2012, 2 pages. [cited by applicant]
Written Opinion of the International Patent Application No. PCT/US2011/063021 dated Mar. 9, 2012, 5 pages. [cited by applicant]
International Preliminary Report of Patentability for International Patent Application No. PCT/US2011/063021 dated Jun. 4, 2013, 6 pages. [cited by applicant]
Office Action in U.S. Appl. No. 18/232,611, mailed May 21, 2025, 8 pages. [cited by applicant]